Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - VERTEX PHARMACEUTICALS INC / MA | a2195217z10-q.htm |
EX-4.1 - EXHIBIT 4.1 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-4_1.htm |
EX-4.2 - EXHIBIT 4.2 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-4_2.htm |
EX-10.4 - EXHIBIT 10.4 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-10_4.htm |
EX-31.1 - EXHIBIT 31.1 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-31_1.htm |
EX-10.5 - EXHIBIT 10.5 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-10_5.htm |
EX-10.2 - EXHIBIT 10.2 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-10_2.htm |
EX-10.6 - EXHIBIT 10.6 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-10_6.htm |
EX-10.1 - EXHIBIT 10.1 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-10_1.htm |
EX-31.2 - EXHIBIT 31.2 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-31_2.htm |
EX-10.3 - EXHIBIT 10.3 - VERTEX PHARMACEUTICALS INC / MA | a2195217zex-10_3.htm |
QuickLinks -- Click here to rapidly navigate through this document
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350,
Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (the "Company"), does hereby certify, to such officer's knowledge, that the Quarterly Report on Form 10-Q for the quarter ended September 30, 2009 (the "Form 10-Q") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 9, 2009 | /s/ MATTHEW W. EMMENS Matthew W. Emmens Chairman, Chief Executive Officer and President (principal executive officer) |
|
Dated: November 9, 2009 |
/s/ IAN F. SMITH Ian F. Smith Executive Vice President and Chief Financial Officer (principal financial officer) |